Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Anticancer Research
|
January 31, 2012
Quantitative MRI establishes the efficacy of PI3K inhibitor (GDC-0941) multi-treatments in PTEN-deficient mice lymphoma
Stephan Wullschleger, Juan M García-Martínez, Suzanne L Duce
Nanotechnology
|
January 29, 2011
Multiwall carbon nanotubes as MRI contrast agents for tracking stem cells
Orazio Vittorio, Suzanne L Duce, Andrea Pietrabissa, et al.
Nature
|
July 27, 2018
Challenges and recent progress in drug discovery for tropical diseases
Manu De Rycker, Beatriz Baragaña, Suzanne L Duce, et al.
The Biochemical Journal
|
December 2, 2014
Decreased adipogenesis and adipose tissue in mice with inactivated protein phosphatase 5
Wright Jacob, Doron Rosenzweig, Cristina Vázquez-Martin, et al.
Journal of the American Chemical Society
|
October 6, 2010
Engineered biocompatible nanoparticles for in vivo imaging applications
Shu Chen, Lijun Wang, Suzanne L Duce, et al.
Plos One
|
February 6, 2013
3D MRI analysis of the lower legs of treated idiopathic congenital talipes equinovarus (clubfoot)
Suzanne L Duce, Mariella D'Alessandro, Yimeng Du, et al.
Cardiovascular Diabetology
|
September 19, 2015
Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging
Suzanne L Duce, Jonathan R Weir-McCall, Stephen J Gandy, et al.
BMC Medical Imaging
|
March 1, 2016
Whole body cardiovascular magnetic resonance imaging to stratify symptomatic and asymptomatic atherosclerotic burden in patients with isolated cardiovascular disease
Jonathan R Weir-McCall, Suzanne L Duce, Stephen J Gandy, et al.
Health Technology Assessment (Winchester, England)
|
March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
Isla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Lancet (London, England)
|
October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Isla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Anticancer Research
|
January 31, 2012
Quantitative MRI establishes the efficacy of PI3K inhibitor (GDC-0941) multi-treatments in PTEN-deficient mice lymphoma
Stephan Wullschleger, Juan M García-Martínez, Suzanne L Duce
Nanotechnology
|
January 29, 2011
Multiwall carbon nanotubes as MRI contrast agents for tracking stem cells
Orazio Vittorio, Suzanne L Duce, Andrea Pietrabissa, et al.
Nature
|
July 27, 2018
Challenges and recent progress in drug discovery for tropical diseases
Manu De Rycker, Beatriz Baragaña, Suzanne L Duce, et al.
The Biochemical Journal
|
December 2, 2014
Decreased adipogenesis and adipose tissue in mice with inactivated protein phosphatase 5
Wright Jacob, Doron Rosenzweig, Cristina Vázquez-Martin, et al.
Journal of the American Chemical Society
|
October 6, 2010
Engineered biocompatible nanoparticles for in vivo imaging applications
Shu Chen, Lijun Wang, Suzanne L Duce, et al.
Plos One
|
February 6, 2013
3D MRI analysis of the lower legs of treated idiopathic congenital talipes equinovarus (clubfoot)
Suzanne L Duce, Mariella D'Alessandro, Yimeng Du, et al.
Cardiovascular Diabetology
|
September 19, 2015
Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging
Suzanne L Duce, Jonathan R Weir-McCall, Stephen J Gandy, et al.
BMC Medical Imaging
|
March 1, 2016
Whole body cardiovascular magnetic resonance imaging to stratify symptomatic and asymptomatic atherosclerotic burden in patients with isolated cardiovascular disease
Jonathan R Weir-McCall, Suzanne L Duce, Stephen J Gandy, et al.
Health Technology Assessment (Winchester, England)
|
March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
Isla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Lancet (London, England)
|
October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Isla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Page
of 1